Danaher Corporation (NYSE:DHR) Stock Price & Quote Analysis

DHR Stock Overview

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.

DHR fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	1/6
Past Performance	4/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 0.4% below our estimate of its fair value

Earnings are forecast to grow 5.75% per year

Earnings grew by 14.9% over the past year

Risk Analysis

Significant insider selling over the past 3 months

My Notes

New

Notes are coming soon

Danaher Corporation Competitors

Thermo Fisher Scientific

NYSE:TMO

US$222.4b

Agilent Technologies

NYSE:A

US$44.9b

IQVIA Holdings

NYSE:IQV

US$42.0b

Mettler-Toledo International

NYSE:MTD

US$33.6b

Price History & Performance

Summary of all time highs, changes and price drops for Danaher
Historical stock prices
Current Share Price	US$262.75
52 Week High	US$303.82
52 Week Low	US$233.71
Beta	0.82
1 Month Change	-1.01%
3 Month Change	8.33%
1 Year Change	-8.54%
3 Year Change	61.43%
5 Year Change	170.74%
Change since IPO	27,022.58%

Recent updates

Does Danaher (NYSE:DHR) Deserve A Spot On Your Watchlist?

Jan 16

A Look At The Fair Value Of Danaher Corporation (NYSE:DHR)

Dec 18

When Should You Buy Danaher Corporation (NYSE:DHR)?

Dec 04

Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?

Nov 20

Is Now The Time To Put Danaher (NYSE:DHR) On Your Watchlist?

Oct 12

A Look At The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Sep 16

Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?

Sep 04

Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?

Jul 19

Should You Be Adding Danaher (NYSE:DHR) To Your Watchlist Today?

Jul 06

Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Jun 09

Is It Time To Consider Buying Danaher Corporation (NYSE:DHR)?

May 27

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Safely

Apr 12

Should You Be Adding Danaher (NYSE:DHR) To Your Watchlist Today?

Mar 28

Danaher (NYSE:DHR) Has A Rock Solid Balance Sheet

Dec 30

Here's Why I Think Danaher (NYSE:DHR) Is An Interesting Stock

Dec 15

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Safely

Oct 01

If You Like EPS Growth Then Check Out Danaher (NYSE:DHR) Before It's Too Late

Sep 16

Estimating The Fair Value Of Danaher Corporation (NYSE:DHR)

Aug 31

Is Danaher (NYSE:DHR) A Risky Investment?

Jul 02

Here's Why I Think Danaher (NYSE:DHR) Is An Interesting Stock

Jun 17

Is Danaher Corporation (NYSE:DHR) Trading At A 25% Discount?

Jun 02

Shareholder Returns

	DHR	US Life Sciences	US Market
7D	-3.3%	-2.2%	0.2%
1Y	-8.5%	-14.5%	-13.6%

Return vs Industry: DHR exceeded the US Life Sciences industry which returned -14.5% over the past year.

Return vs Market: DHR exceeded the US Market which returned -13.6% over the past year.

Price Volatility

Is DHR's price volatile compared to industry and market?
DHR volatility
DHR Average Weekly Movement	4.9%
Life Sciences Industry Average Movement	11.7%
Market Average Movement	6.9%
10% most volatile stocks in US Market	17.3%
10% least volatile stocks in US Market	2.8%

Stable Share Price: DHR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: DHR's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1969	81,000	Rainer Blair	https://www.danaher.com

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Danaher Corporation Fundamentals Summary

How do Danaher's earnings and revenue compare to its market cap?
DHR fundamental statistics
Market Cap	US$191.36b
Earnings (TTM)	US$7.10b
Revenue (TTM)	US$31.47b

26.9x

P/E Ratio

6.1x

P/S Ratio

Is DHR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
DHR income statement (TTM)
Revenue	US$31.47b
Cost of Revenue	US$12.52b
Gross Profit	US$18.95b
Other Expenses	US$11.85b
Earnings	US$7.10b

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	9.75
Gross Margin	60.21%
Net Profit Margin	22.57%
Debt/Equity Ratio	39.3%

How did DHR perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

10%

Payout Ratio

DHR Stock Overview

Rewards

Risk Analysis

Danaher Corporation Competitors

NYSE:TMO

US$222.4b

NYSE:A

US$44.9b

NYSE:IQV

US$42.0b

NYSE:MTD

US$33.6b

Price History & Performance

Recent News & Updates

Independent Director exercised options and sold US$1.4m worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Danaher Q4 2022 Earnings Preview

Does Danaher (NYSE:DHR) Deserve A Spot On Your Watchlist?

We Have A Winner! Revisiting Danaher And Thermo Fisher

Danaher Corporation Revises Revenue Guidance for the Fourth Quarter of 2022

Recent updates

Independent Director exercised options and sold US$1.4m worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Does Danaher (NYSE:DHR) Deserve A Spot On Your Watchlist?

Danaher Corporation Revises Revenue Guidance for the Fourth Quarter of 2022

Danaher Corporation to Report Q4, 2022 Results on Jan 24, 2023

Upcoming dividend of US$0.25 per share

A Look At The Fair Value Of Danaher Corporation (NYSE:DHR)

Danaher Corporation Announces Quarterly Dividends, Payable on January 27, 2023

When Should You Buy Danaher Corporation (NYSE:DHR)?

Executive Vice President recently sold US$774k worth of stock

Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?

Insider recently sold US$512k worth of stock

CFO & Executive VP exercised options and sold US$4.1m worth of stock

Independent Director exercised options to buy US$753k worth of stock.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Is Now The Time To Put Danaher (NYSE:DHR) On Your Watchlist?

Now 21% undervalued

Danaher Corporation to Report Q3, 2022 Results on Oct 20, 2022

Upcoming dividend of US$0.25 per share

A Look At The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on October 28, 2022

Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?

President exercised options and sold US$5.8m worth of stock

Executive Vice President recently sold US$3.3m worth of stock

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?

Independent Director exercised options to buy US$1.2m worth of stock.

Should You Be Adding Danaher (NYSE:DHR) To Your Watchlist Today?

Danaher Corporation Appoints Feroz Dewan to the Board

Danaher Corporation to Report Q2, 2022 Results on Jul 21, 2022

Upcoming dividend of US$0.25 per share

Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

SCIEX and Danaher Corporation Launches Zeno SWATH DIA

Is It Time To Consider Buying Danaher Corporation (NYSE:DHR)?

Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on July 29, 2022

Executive Vice President recently sold US$1.7m worth of stock

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Safely

Danaher Corporation Announces Executive Changes

Danaher Corporation, Annual General Meeting, May 10, 2022

Should You Be Adding Danaher (NYSE:DHR) To Your Watchlist Today?

Danaher Corporation to Report Q1, 2022 Results on Apr 21, 2022

Upcoming dividend of US$0.25 per share

Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on April 29, 2022

Senior VP recently sold US$1.6m worth of stock

Executive Vice President exercised options and sold US$4.9m worth of stock

Full year 2021 earnings: EPS exceeds analyst expectations

Danaher Corporation Provides Revenue Guidance for the Fourth Quarter 2021

Danaher (NYSE:DHR) Has A Rock Solid Balance Sheet

Upcoming dividend of US$0.21 per share

Here's Why I Think Danaher (NYSE:DHR) Is An Interesting Stock

Insider exercised options and sold US$9.8m worth of stock

CFO & Executive VP recently sold US$843k worth of stock

Lead Independent Director exercised options and sold US$1.2m worth of stock

Co-Founder & Director recently sold US$378m worth of stock

Co-Founder & Director notifies of intention to sell stock

Third quarter 2021 earnings released: EPS US$1.56 (vs US$1.19 in 3Q 2020)

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Safely